Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00749359 · ClinicalTrials.gov registry record · Phase 1
PAXIL CR Bioequivalence Study
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 166
- Enrollment target
NCT00749359 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 166 participants.
The verdict
NCT00749359, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 166 participants
- Enrollment target
Study Summary
This study is to determine if controlled release paroxetine tablets manufactured at two different sites behave similarly in healthy volunteers.
Interventions
- DRUG Paxil CR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2008-07-07 |
| Est. Completion | 2008-09-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00749359
The ClinicalTrials.gov registry entry for NCT00749359 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Paxil CR is the first listed.
NCT00749359 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00749359 about?
NCT00749359 is a clinical study titled "PAXIL CR Bioequivalence Study". This study is to determine if controlled release paroxetine tablets manufactured at two different sites behave similarly in healthy volunteers.
What is the current status of trial NCT00749359?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 166 participants. The study started on 2008-07-07. Estimated completion is 2008-09-16.
What interventions are being tested in trial NCT00749359?
The interventions under investigation include: Paxil CR (DRUG).
Who is sponsoring clinical trial NCT00749359?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.